Leserbrief
Comment on “Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination”
Cutis · 2024
DOI: 10.12788/cutis.1072 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cutis, 2024. Verfasst von Hinpetch Daungsupawong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Daungsupawong is from Private Academic Consultant, Phonhong, Lao People's Democratic Republic. Dr. Wiwanitkit is from the Department of Research …. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Pityriasis Rubra Pilaris.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
COVID-19 VaccinesPityriasis Rubra PilarisHumansCOVID-19
Substanzen
COVID-19 Vaccines
Autor:innen und Institutionen
- Dr. Daungsupawong is from Private Academic Consultant, Phonhong, Lao People's Democratic Republic. Dr. Wiwanitkit is from the Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute o…
Zitieren
APA
Daungsupawong, H., & Wiwanitkit, V. (2024). Comment on “Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination”. Cutis. https://doi.org/10.12788/cutis.1072
Vancouver
Daungsupawong H, Wiwanitkit V. Comment on “Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination”. Cutis. 2024. doi:10.12788/cutis.1072
BibTeX
@article{Daungsupawong2024,
author = {Daungsupawong, Hinpetch and Wiwanitkit, Viroj},
title = {Comment on “Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination”},
journal = {Cutis},
year = {2024},
doi = {10.12788/cutis.1072}
}
EUVIMED